Live tape
Top 8, mentions 7d7,350SPCX1,444 mentions▲ +0.09GOOGL1,345 mentions▲ +0.05NVDA1,196 mentions▲ +0.09MSFT840 mentions▲ +0.04QQQ693 mentions▲ +0.08META639 mentions▲ +0.04SPY601 mentions▲ +0.06AMZN592 mentions▲ +0.07

Equity · Healthcare

REGN

NASDAQ

Regeneron Pharmaceuticals, Inc.

$802 −0.25% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 23, 2026
Price · Chart
52 sessions
$900 $600 13 Jul 23 Sep

The line runs $663 on 13 July through $802 on 23 September, on a scale from $600 to $900. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 52 sessions, 13 Jul – 23 Sep 2026
Market cap $85.7B
P/E (TTM) 19.9
52-week range $556 – $852
Avg volume 26.4K

as of Sep 23, 2026

REGN insider trades

SEC Form 4

REGN has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 9 December 2025.

Date Insider Type Shares Value
20 Nov 2025 Bassler Bonnie L Sell 760 $570K
07 Nov 2025 Pitofsky Jason VP Controller Sell 431 $281K
29 Oct 2025 POON CHRISTINE A Sell 6,500 $4.25M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
09 Dec 2025 Van Plew Daniel P EVP & General Mgr, Industrial Tax withheld 2,552 $1.79M
09 Dec 2025 YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO Tax withheld 131,874 $92.51M
09 Dec 2025 YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO Option exercise 146,815 $81.58M
09 Dec 2025 SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO Tax withheld 155,145 $108.84M
09 Dec 2025 SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO Option exercise 172,723 $95.98M
09 Dec 2025 McCourt Marion EVP Commercial Tax withheld 1,021 $716K
09 Dec 2025 MURPHY ANDREW J EVP Research Tax withheld 4,229 $2.97M
08 Dec 2025 LAROSA JOSEPH J EVP General Counsel and Secret Tax withheld 1,396 $995K
08 Dec 2025 Van Plew Daniel P EVP & General Mgr, Industrial Tax withheld 1,906 $1.36M
08 Dec 2025 Fenimore Christopher R. EVP Finance CFO Tax withheld 992 $707K
08 Dec 2025 McCourt Marion EVP Commercial Tax withheld 1,336 $952K
08 Dec 2025 MURPHY ANDREW J EVP Research Tax withheld 1,699 $1.21M

Showing the 12 most recent of 27 compensation filings in this window. The figures above count all of them.

REGN reported financials

SEC EDGAR XBRL SEC EDGAR

REGN reported revenue of $14.3B for the fiscal year ended 31 Dec 2025. Net income over the same period was $4.5B.

Figure Reported Period
Revenue $14.3B 31 Dec 2025 fiscal year
Net income $4.5B 31 Dec 2025 fiscal year
Diluted EPS $41.48 31 Dec 2025 fiscal year
Total assets $41.7B 30 Jun 2026 at period end
Total equity $31.7B 30 Jun 2026 at period end

REGN earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $12.23 —
31 Mar 2026 Q1 2026 $6.75 —
31 Dec 2025 FY 2025 $41.48 —
30 Sep 2025 Q3 2025 $13.62 —
30 Jun 2025 Q2 2025 $12.81 —
31 Mar 2025 Q1 2025 $7.27 —
31 Dec 2024 FY 2024 $38.34 —
30 Sep 2024 Q3 2024 $11.54 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

REGN institutional holders

SEC Form 13F SEC EDGAR

11 of the 45 institutional funds we track reported a REGN position for the quarter ended 30 Jun 2026 — a combined $1.7B; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
AQR Capital Management Held (±25%) −8.5% shares 1,126,080 $702.2M
Two Sigma Investments Held (±25%) −19.2% shares 656,124 $409.1M
Man Group Added +38.6% shares 436,956 $272.5M
Millennium Management Added +163.2% shares 165,120 $103.0M
Renaissance Technologies Added +121.9% shares 148,222 $92.4M
Citadel Advisors Held (±25%) +20.8% shares 57,604 $35.9M
Bridgewater Associates Added +125.9% shares 51,333 $32.0M
D. E. Shaw & Co. Added +69.3% shares 38,477 $24.0M
Marshall Wace Added +6,415.6% shares 23,000 $14.3M
Balyasny Asset Management Added +526.7% shares 9,432 $5.9M

Showing the 10 largest of 11 reported positions. The figures above count all of them.

REGN fails-to-deliver

SEC CNS data SEC

On 09 Sep 2026, 341 shares of REGN failed to deliver (about $276K).

Settlement date Shares failed Notional % of shares out
09 Sep 2026 341 $276K <0.001%
03 Sep 2026 1,556 $1.3M 0.001%

Congressional trades in REGN

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in REGN is a sale by Gilbert Ray Cisneros, Jr. (house, CA), dated 15 May 2026.

Date Member Type Amount
15 May 2026 filed 08 Jun 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Sale $1K–$15K
18 Nov 2025 filed 15 Dec 2025 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
15 May 2025 filed 09 Jun 2025 Robert P. Bresnahan, Jr. house · Republican–PA Purchase $1K–$15K
10 Apr 2025 filed 24 May 2025 Byron Donalds house · Republican–FL Sale $1K–$15K
08 Apr 2025 filed 08 May 2025 Robert P. Bresnahan, Jr. house · Republican–PA Sale $1K–$15K
07 Apr 2025 filed 08 May 2025 Jefferson Shreve house · Republican–IN Sale $15K–$50K
01 Apr 2025 filed 14 May 2025 Julie Johnson house · Democrat–TX Sale $1K–$15K
25 Feb 2025 filed 27 Mar 2025 Robert P. Bresnahan, Jr. house · Republican–PA Sale $1K–$15K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings
  8. Wikipediatext of the lead paragraph, licensed CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) — https://en.wikipedia.org/wiki/Regeneron_Pharmaceuticals